CLSI M52 (R2020)
Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, M52Ed1E
standard by Clinical and Laboratory Standards Institute, 08/01/2015
- Comments Off on CLSI M52 (R2020)
- CLSI
Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, M52Ed1E
standard by Clinical and Laboratory Standards Institute, 08/01/2015
Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement, M31-S1
standard by Clinical and Laboratory Standards Institute, 05/01/2004
Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline, Second Edition, H42-A2
standard by Clinical and Laboratory Standards Institute, 05/01/2007
Quality Management System: Qualifying, Selecting, and Evaluating a Referral Laboratory; Approved Guideline – Second Edition, QMS05A2E
standard by Clinical and Laboratory Standards Institute, 09/01/2012
Red Blood Cell Diagnostic Testing Using Flow Cytometry; Approved Guideline – Second Edition, H52A2E
standard by Clinical and Laboratory Standards Institute, 03/01/2014
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE
standard by Clinical and Laboratory Standards Institute, 07/01/2004
Selection Criteria for Point-of-Care Testing Devices; Approved Guideline, POCT09A
standard by Clinical and Laboratory Standards Institute, 04/01/2010
Principles and Procedures for Detection of Fungi in Clinical Specimens – Direct Examination and Culture; Approved Guideline, M54A
standard by Clinical and Laboratory Standards Institute, 10/01/2012
Using Proficiency Testing and Alternative Assessment to Improve Medical Laboratory Quality, QMS24Ed3E
standard by Clinical and Laboratory Standards Institute, 09/01/2016